The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Poster Session

Sun. Oct, 14

Poster Session 3-11 CML: Clinical (2)

Sun. Oct 14, 2018 12:40 PM - 1:20 PM Poster1 (Osaka International Convention Center, 3F Event Hall)

Chair: Noriyoshi Iriyama (Hematology & Rheumatology, Nihon University School of Medicine)

[PS3-11-3] Nilotinib is safe and effective for a patient with CML-CP under hemodialysis

Azusa Ikeuchi1,2, Makiko Horai1, Hidehiro Itonaga1, Sachie Tsukada1,2, Hikaru Sakamoto1, Hideaki Kitanosono1, Masataka Taguchi1, Shinya Sato1, Koji Ando1, Yasushi Sawayama1, Yoshitaka Imaizumi1, Tomoko Hata1, Yukiyoshi Moriuchi2, Yasushi Miyazaki1 (1.Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan, 2.Department of Hematology, Sasebo City General Hospital, Sasebo, Japan)

Abstract password authentication.
Password is written on a program and abstract book.

Password